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Abstract 
The correlation of the length of time undergoing hemodialysis with the levels of hemoglobin, 
hematocrit, serum iron and total iron binding capacity in patients with chronic kidney disease at 
RSUD Prof. Dr. W. Z. Johannes Kupang. People with chronic kidney disease who are 
performing Hemodialysis suffer from anemia. Blood loss during the hemodialysis process is 
affected by frequent blood sampling for laboratory tests. To diagnose the occurrence of iron 
deficiency, anemia laboratory tests such as complete blood, serum iron (SI), TIBC, transferrin 
saturation, and serum ferritin can be conducted. The objective of this study is to determine the 
correlation between the length of undergoing Hemodialysis with the levels of Hemoglobin, 
Hematocrit, Serum Iron, and Total Iron Binding Capacity (TIBC) in patients with chronic 
kidney disease in RSUD Prof. Dr.W. Z Johannes Kupang. This study employed an anon-
reactive research design or unobtrusive research based on secondary data derived from medical 
record records at RSUD Prof. Dr.W. Johannes in August - September 2019 on 92 hemodialysis 
patients who met the inclusion criteria. The collected data were calculated with the SPSS 
application, while the correlation analysis between variables was performed by administering a 
linear regression analysis test. Ninety-two (92) respondents were obtained by employing the 
purposive sampling technique. The majority of patients with chronic kidney disease undergoing 
Hemodialysis were men (57.6%) with ages 39 - 59 years (63.0%), and the majority of patients 
undergoing Hemodialysis in patients with chronic kidney failure (CKD) were <12 months 
(41.3%). It was discovered that there was no relationship between the length of Hemodialysis 
with hemoglobin, hematocrit, serum iron, and total iron-binding capacity levels in patients with 
chronic kidney disease (CKD). 
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Kidneys are vital organs in humans that possess a tremendous essential role in the 
body's metabolism. If there is a disturbance in kidney function caused by chronic 
disease, it affects the function of other organs in the body. Chronic Kidney Failure 
(CKD) is a non-communicable disease (NCD) that has become a global public health 
issue due to increased prevalence and incidence of kidney failure, poor prognoses, and 
high expenses. According to the World Health Organization (WHO), chronic kidney 
disease, with an annual mortality rate of 850.000 individuals, contributes to the world's 
disease burden (World Health Organization, 2003). The prevalence of CKD rises in 
tandem with the aging population and the rise in the frequency of hypertension and 
diabetes mellitus (Kementerian Kesehatan Republik Indonesia, 2018). Chronic kidney 
disease (CKD) is a global health problem whose prevalence has increased. The state of 
fluid overload is often a systemic complication of CKD patients undergoing 
hemodialysis (HD) therapy. One of the clinical parameters of fluid overload in HD 
patients is ascites (Yusman, et al, 2020). 
Chronic Kidney Disease is a non-communicable disease affecting the kidney 
organ, in which the kidney organ suffers from severe damage due to the decreased 
glomerular filtration rate (Permatasari, 2019). Basic Health Research data in 2018 
reported that the prevalence of the Indonesian population suffering from kidney failure 
reaches 3.8%, and the province of East Nusa Tenggara attains 2% suffering from 
chronic kidney failure (Kementerian Kesehatan Republik Indonesia, 2018). 
Chronic kidney failure or end-stage renal disease (ESRD) is a progressive and 
irreversible renal function disorder in which the ability of the body fails to maintain 
metabolism, fluid, and electrolyte balance, causing uremia (Simatupang, 2019). Chronic 
kidney disease can be caused by various conditions such as vascular disease, chronic 
glomerular disease, chronic infections, hypertension, diabetes, obstruction processes, 
and others. The kidneys can be translated for the treatment, or dialysis/hemodialysis can 
be used. Hemodialysis, frequently known as dialysis, is a kidney replacement therapy 
that cleans metabolic residue from the blood. It is most commonly used in patients with 
chronic kidney failure to extend and improve their quality of life. Low blood pressure, 
sepsis signs such as high fever and disorientation, muscular cramps, sleeplessness, and 
bone and joint pain are all side effects of hemodialysis (Permatasari, 2019).  
Hemodialysis is a method of transferring dissolved compounds with products 
remaining in the body. Residual compounds collected in patients with CKD were 
obtained attractively by administering a semipermeable membrane passive diffusion 
method. The transfer of substances or compounds remaining in metabolic products 
works by following a decrease in the concentration gradient in the circulation into the 
dialysate (Aisara, et al., 2018). One method of managing chronic kidney disease is 
hemodialysis. Hemodialysis therapy takes a long time, has complications, and requires 
patient compliance. This will give the patient physiological and psychological stressors, 
affecting the patient's quality of life (Fitriani et al., 2020). Hemodialysis has developed 
as replacement therapy for renal function. Correctly understanding the patient's 
condition and providing the necessary care is at the core of patient care. Furthermore, 
optimal care of patients with the end-stage renal disease requires a thorough 
understanding of the different treatment options related to dialysis. In comparison, 
dialysis patterns may differ from country to country depending on national health 
policies (Kim & Kawanishi, 2018). 
Djami, S. W., & Tangkelangi, M.  (2021). Hemodialysis Duration with Levels of Hemoglobin, Hematocrit, 
Serum Iron and Total Iron Binding Capacity on Chronic Kidney Disease. JURNAL INFO KESEHATAN,  
19(2), 197-205. https://doi.org/10.31965/infokes.Vol19Iss2.523 
| 199 
 
The highest increase in the number of patients with chronic kidney failure 
undergoing hemodialysis occurred in the 45–64-year age group, patients actively 
undergoing hemodialysis. Patients with chronic kidney failure who are 
performinghemodialysis suffer from anemia. Blood loss during the hemodialysis 
process is affected by frequent blood collection for laboratory and other examinations, 
characterized by a decrease in transferrin saturation and reduced ferritin levels. 
Laboratory tests such as Complete Blood, Serum Iron (SI), Total Iron Binding Capacity 
(TIBC), transferrin saturation, and serum ferritin are performed to diagnose iron-
deficiency anemia. Chronic kidney failure, also understood as CKD or chronic kidney 
disease, is characterized by a significant decrease in kidney function, which is 
frequently up to less than 20% of the normal GFR value, over a long period, usually >3 
months. Chronic kidney disease lasts without symptoms for years with increasing 
uremia and accompanying symptoms when the GFR has dropped to below 60 mL/min. 
The causes of chronic kidney failure are all in the form of long-term chronic disease 
(Indri, 2020). 
According to Rachmanto, 2018, hemodialysis is a therapy that is performed to 
replace the work function of the kidneys by utilizing a tool specifically designed to treat 
symptoms and signs due to low levels of GFR patient's quality of life. In simple terms, 
hemodialysis is interpreted as a method of washing blood by removing excess waste or 
harmful compounds through a semipermeable membrane conducted to replace kidney 
function that is not functioning properly. Hemodialysis cleans and replaces the work 
that healthy kidneys are supposed to function. Hemodialysis should be conducted for 
the rest of the life of patients with decreased renal function until the patient receives a 
kidney transplant. If the transplant is not successful, hemodialysis can be performed 
again.. 
Wahyuni, et al., 's research 2018 study, there was a significant relationship 
between hemodialysis duration and quality of life in patients with chronic kidney 
disease, while Permatasari in 2019, study revealed no link between hemodialysis length 
and hemoglobin, hematocrit, or serum iron levels in patients with chronic kidney 
failure. The study on the length of hemodialysis with hemoglobin (Hb), hematocrit (Ht), 
serum iron (SI), and Total Iron Binding Capacity (TIBC) levels in kidney failure 
patients in Prof. Dr. WZ. Hospital Johannes Kupang, Indonesia, considers anemia's 
influence on kidney failure patients receiving hemodialysis. 
 
2. RESEARCH METHOD 
This study employeddescriptive analysis with frequency distribution tables of the 
patients' characteristics with chronic kidney failure undergoing hemodialysis in the form 
of age, sex, level of education and employment. This research is non-reactive research 
based on secondary data, in which the secondary data comes from medical records in 
RSUD Prof. Dr. W. Z. Johannes Kupang. This study was conducted on 92 patients 
undergoing hemodialysis in the hemodialysis unit of RSUD Prof. Dr. W. Z. Johannes 
Kupang General Hospital in August-September 2019. Moreover, this study was 
performed in patients with chronic kidney failure who underwent hemodialysis by 
looking at the results of their medical records which objective is to identify the 
correlation between length of time undergoing hemodialysis with hemoglobin, 




The research data obtained were assessed by the SPSS application, while the 
correlation analysis between variables and data analysis results are presented in 
narration and frequency distribution tables. Results revealed significant when p<0.05. 
This research has also received research ethics permit from the Faculty of Medicine, 
University of Nusa Cendana with no. 45/UN15.16/KEPK/2019. 
 
3. RESULTS AND DISCUSSION 
Table 1. Characteristics of Respondents by Age. 
Age Frequency Percent 
18 – 38 Year 9 9.8 
39 – 59 Year 58 63.0 
60 – 80 Year 25 27.2 
Total 92 100.0 
Based on Table 1, it is displayed that the age of chronic kidney failure patients 
undergoing hemodialysis is mainly in the age group 39-59 years as many as 58 
respondents (63.0%). Chronic kidney failure is a non-communicable disease affecting 
the kidney organ, in which the kidney organ suffers from severe damage due to a 
decreased glomerular filtration rate. 
Based on research by Dharmawan, et al. in 2018, it was stated that patients 
undergoing hemodialysis were more common in the elderly or older than 40 years who 
often took hypertension drugs. Djami, et al.'s research in 2018 also stated that 
hypertension complications can affect various organs such as the heart (ischemic heart 
disease, left ventricular hypertrophy, heart failure), brain (stroke), kidneys (kidney 
failure), eyes (retinopathy) as well as peripheral arteries (intermittent claudication). The 
damage to these organs depends on the patient's high blood pressure and how long the 
high blood pressure is uncontrolled and untreated. 
Table 2. Characteristics of Respondents by Gender. 
Gender Frequency Percent 
Male 53 57.6 
Female 39 42.4 
Total 92 100.0 
Based on Table 2, the sex of chronic renal failure patients undergoing 
hemodialysis is the most male sex with 53 respondents (57.6%), and the least is the 
female sex with the number of 39 respondents (42.4%). Basic Health Research data in 
2013 which shows that CKD patients are more common in men than women 
(Kementerian Kesehatan Republik Indonesia, 2013). These results were the same as 
Winalda's research in 2018 showed that the most extensive distribution of respondents 
according to gender was male by 52 people (52.0%). 
Table 3. Characteristics of Respondents by Education Level. 
Education Level Frequency Percent 
Primary School 9 9.8 
Junior High School 15 16.3 
Senior High School 41 44.6 
Diploma 4 4.3 
Bachelor 23 25.0 
Total 92 100.0 
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Based on Table 3, it is presented that the level of education of chronic kidney 
failure patients undergoing hemodialysis is mostly the level of high school education 
with a number of 41 respondents (44.6%), and for the least educational level is Diploma 
and 4 respondents (4.3%). 
Table 4. Characteristics of Respondents Based on Employment Status. 
Employment Frequency Percent 
An Worker 38 41.3 
Entrepreneur 26 28.3 
Civil Servant 27 29.3 
Army 1 1.1 
Total 92 100.0 
Based on Table 4, the occupational status of chronic kidney failure patients 
undergoing hemodialysis is largely not working with 38 respondents (41.3%). The 
occupational status of chronic kidney failure patients undergoing hemodialysis is the 
least with Indonesian Armies with only 1 respondent (1.1%). 
Table 5. Duration of Hemodialysis. 
Duration of Hemodialisis Frequency Percent 
< 12 Month 38 41.3 
12 – 24 Month 34 37.0 
> 24 Month 20 21.7 
Total 92 100.0 
Based on Table 5 the length of time to undergo hemodialysis in patients with 
chronic kidney failure is the most <12 months with 38 respondents (41.3%). 
Table 6. Hemoglobin levels. 
Hemoglobin Frequency Percent 
Low 92 100.0 
Normal 0 0.0 
High 0 0.0 
Total 92 100.0 
Based on Table 6, it can be concluded that the overall hemoglobin level in patients 
with chronic kidney failure is decreased by a total of 92 respondents (100%). The 92 
respondents who suffered from chronic kidney failure and were undergoing 
hemodialysis as a whole had a hemoglobin level <13 g / dl (100.0%).  
The research results by Agustina, et al. (2019) showed a significant difference 
between pre and post hemodialysis Hb levels in chronic kidney disease patients, where 
post hemodialysis Hb levels were lower than pre hemodialysis Hb levels. This is 
because a small amount of blood is usually left in the dialyzer. This can be a source of 
iron deficiency over time, leading to anemia. 
Table 7. Hematocrit levels. 
Hematocrit Frequency Percent 
Low 91 98.9 
Normal 1 1.1 
High 0 0.0 
Total 92 100.0 
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Based on Table 7, it can be concluded that overall hematocrit levels in patients 
with chronic kidney failure are decreased by 91 respondents (98.9%). It was found that 
the incidence of anemia in patients with chronic kidney disease was 98.5%, with an 
average Hb level of 7.3 g/dl and an average glomerular filtration rate of 8.81 
ml/minute/1.73 m2. From the Pearson correlation test results, it was found that there was 
a relationship between the incidence of anemia and chronic kidney disease (Hidayat, et 
al., 2016). 
Table 8. Serum Iron levels. 
Serum Iron Frequency Percent 
Low 25 27.2 
Normal 56 60.8 
High 11 12.0 
Total 92 100.0 
Based on Table 8, it can be concluded that most Serum Iron (SI) levels in chronic 
kidney raga sufferers are normal, with 56 respondents (60.8%). Of the 92 respondents 
who suffered from chronic kidney failure and were undergoing hemodialysis, as many 
as 25 respondents (27.2%) had serum iron <65 ug / dL. Absolute Iron Deficiency 
Anemia (IDA) is one of the complications in patients undergoing hemodialysis, with an 
incidence of 76.4%. If this condition is not treated properly, it can impair heart function 
and increase mortality. The incidence of this case is between 30−45%. Determining iron 
status in hemodialysis patients using serum ferritin and transferrin saturation did not 
significantly change the value of the initial state of iron deficiency (Rachmiwatie, et al., 
2018). 
Table 9. Total Iron Binding Capacity (TIBC). 
Total Iron Binding Capacity (TIBC) Frequency Percent 
Low 14 15.2 
Normal 62 67.4 
High 16 17.4 
Total 92 100.0 
Based on Table 9, it can be concluded that the majority of the Total Iron Binding 
Capacity (TIBC) in chronic renal disease sufferers is normal, with 62 respondents 
(67.4%). This study found levels of Total Iron Binding Capacity (TIBC) decreased by 
14 respondents (15.2%), and as many as 16 respondents (17.4%) had high SI 
levels/increased. Serum transferrin estimated by measurement of total iron-binding 
capacity is one of the energy and protein malnutrition markers. On chronic kidney 
disease, anemia often occurs due to anemia deficiency. TIBC is indirectly from iron 
stores from transferrin (Pradipta, et al., 2018). 
Table 10. Correlation of the Duration of Hemodialysis with the Levels of Hemoglobin, 
Hematocrit, Serum Iron and Total Iron Binding Capacity (TIBC) in Chronic Kidney 




Serum Iron (SI) 0.561 
Total Iron Binding Capacity (TIBC) 0.606 
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Based on table 10, it can be identified the results of the correlation spearmen test 
of the relationship between the length of undergoing hemodialysis with hemoglobin and 
hematocrit levels in patients with chronic kidney failure undergoing hemodialysis 
obtained Sig. in hemoglobin of 0.682 (>0.05) and Sig. in hematocrit of 0.147 (>0.05). 
Thus, it is identified that there is no relationship between the length of undergoing 
hemodialysis with hemoglobin and hematocrit levels in patients with chronic kidney 
failure. Sig value in Serum Iron value is 0.561 (>0.05), and Sig value in Total Iron 
Binding Capacity is 0.606 (>0.05). It can be indicated that there is no relationship 
between the length of undergoing hemodialysis with Serum Iron levels and Total Iron 
Binding Capacity levels in patients with chronic kidney failure. 
4. CONCLUSION 
In general, patients with chronic kidney failure on hemodialysis are 39-59 years 
old, male, high school educated, and unemployed. Patients with chronic kidney failure 
who receive hemodialysis at the RSUD Prof. W. Z Johannes Kupang General Hospital 
have a maximum of one-year stay. The majority of chronic kidney failure patients on 
hemodialysis have low hematocrit and low hemoglobin levels. Most hemodialysis 
patients with chronic kidney failure possess normal Serum Iron and Total Iron Binding 
Capacity levels. In patients with chronic kidney disease, there is no link between the 
length of time spent on hemodialysis and hemoglobin, hematocrit, serum iron, or total 
iron-binding capacity in patients with chronic kidney failure. 
Further research needs to be conducted by comparing the levels of hemoglobin, 
hematocrit, serum iron, and total iron-binding capacity before and after hemodialysis in 
patients with chronic kidney failure. Moreover, caution must be considered to ensure the 
length of data undergoing hemodialysis to eliminate bias.. 
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